U.K.'s Competition Watchdog Opens Probe into Roche Takeover of Spark Therapeutics
October 22 2019 - 2:46AM
Dow Jones News
By Carlo Martuscelli
The U.K.'s Competition and Markets Authority has opened an
investigation into the acquisition of Spark Therapeutics Inc. by
Roche Holding AG (RO.EB).
The regulator said it is looking into whether the deal will
result in a substantial lessening of competition, and has set Dec.
16 as its deadline to decide whether it will continue the
investigation.
Roche said it agreed to buy the Philadelphia biotechnology
company in February in a bid to expand its presence in hemophilia
treatment.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com;
@carlomartu
(END) Dow Jones Newswires
October 22, 2019 02:31 ET (06:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
